CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion | +5,000 | $7.27 | $36K | 40,454 |
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion | +2,000 | $8.63 | $17K | 42,454 |
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion · Incentive Stock Option (right to buy) | −5,000 | 20,000 | ||
| 2010-02-18 | Capone Mark Christopher Chief Operating Officer, MGL | Exercise or conversion · Incentive Stock Option (right to buy) | −2,000 | 10,000 |
Page 1 of 1 · 4 trades